Bausch Health Companies Inc. (BHC)
NYSE: BHC · Real-Time Price · USD
5.57
-0.06 (-1.07%)
At close: Mar 5, 2026, 4:00 PM EST
5.57
0.00 (0.00%)
After-hours: Mar 5, 2026, 6:30 PM EST
Bausch Health Companies Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Bausch Health Companies stock have an average target of 8.33, with a low estimate of 7.00 and a high estimate of 10. The average target predicts an increase of 49.55% from the current stock price of 5.57.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Bausch Health Companies stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 4 | 4 | 3 | 4 | 3 |
| Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 3 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | +25.67% | Feb 25, 2026 |
| Truist Securities | Truist Securities | Hold Maintains $7 → $8 | Hold | Maintains | $7 → $8 | +43.63% | Jan 7, 2026 |
| Barclays | Barclays | Hold Initiates $8 | Hold | Initiates | $8 | +43.63% | Dec 9, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $8.5 → $10 | Hold | Maintains | $8.5 → $10 | +79.53% | May 2, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $9 → $8.5 | Hold | Maintains | $9 → $8.5 | +52.60% | Apr 7, 2025 |
Financial Forecast
Revenue This Year
10.73B
from 10.27B
Increased by 4.48%
Revenue Next Year
10.71B
from 10.73B
Decreased by -0.12%
EPS This Year
4.36
from 0.42
Increased by 938.08%
EPS Next Year
4.07
from 4.36
Decreased by -6.65%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 11.3B | 11.4B | |||
| Avg | 10.7B | 10.7B | |||
| Low | 10.3B | 10.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 9.6% | 5.9% | |||
| Avg | 4.5% | -0.1% | |||
| Low | 0.0% | -6.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 5.00 | 5.01 | |||
| Avg | 4.36 | 4.07 | |||
| Low | 3.64 | 3.27 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 1,090.0% | 14.9% | |||
| Avg | 938.1% | -6.6% | |||
| Low | 767.3% | -24.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.